-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab Biosimilar in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab Biosimilar in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab Biosimilar in Solid Tumor Drug Details: Pembrolizumab (BAT-3306) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HIV-1 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HIV-1 in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HIV-1 in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IOV-1042 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IOV-1042 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IOV-1042 in Solid Tumor Drug Details: IOV-1042 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HBM-1020 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HBM-1020 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HBM-1020 in Metastatic Colorectal Cancer Drug Details: HBM-1020 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAVO-412 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAVO-412 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAVO-412 in Gastric Cancer Drug Details: TAVO-412 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AXER-204 in Chronic Spinal Cord Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AXER-204 in Chronic Spinal Cord Injury report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AXER-204 in Chronic Spinal Cord Injury Drug Details: AXER-204...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bimekizumab in Ankylosing Spondylitis (Bekhterev’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimekizumab in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimekizumab in Ankylosing Spondylitis (Bekhterev's Disease) Drug Details: Bimekizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MyMD-1 in Sarcopenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MyMD-1 in Sarcopenia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MyMD-1 in Sarcopenia Drug Details: MyMD-1 (Isomyosamine) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Soft Tissue Sarcoma Drug Details: Toripalimab (Tuoyi, Loqtorzi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – THN-391 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - THN-391 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. THN-391 in Alzheimer's Disease Drug Details: THN-391 is under development for...